Thoratec Scouting Cardiac Cell Delivery Catheter Applications For LVAD
This article was originally published in The Gray Sheet
Executive Summary
Thoratec's equity investment in BioCardia reflects the firm's desire to explore combination therapies in anticipation of future heart failure trends
You may also be interested in...
Financings In Brief
Digirad IPO: San Diego firm plans to use the approximately $59.7 mil. in proceeds from June 9 initial public offering to expand its nuclear cardiology business and solid-state gamma camera leasing service, rebuild its sales and marketing capabilities and repay about $9.4 mil. in debt. The offering consists of 5.5 mil. shares priced $12 each. Digirad owes Silicon Valley Bank roughly $4.8 mil. and GE Healthcare Financial Services $4.5 mil. (1"The Gray Sheet" March 29, 2004, p. 15). Joint managers for the offering were Merrill Lynch, JP Morgan Securities and Pierce, Fenner & Smith; Banc of America Securities and William Blair & Company are acting as co-managers. Digirad is listed on Nasdaq as "DRAD"...
Financings In Brief
Digirad IPO: San Diego firm plans to use the approximately $59.7 mil. in proceeds from June 9 initial public offering to expand its nuclear cardiology business and solid-state gamma camera leasing service, rebuild its sales and marketing capabilities and repay about $9.4 mil. in debt. The offering consists of 5.5 mil. shares priced $12 each. Digirad owes Silicon Valley Bank roughly $4.8 mil. and GE Healthcare Financial Services $4.5 mil. (1"The Gray Sheet" March 29, 2004, p. 15). Joint managers for the offering were Merrill Lynch, JP Morgan Securities and Pierce, Fenner & Smith; Banc of America Securities and William Blair & Company are acting as co-managers. Digirad is listed on Nasdaq as "DRAD"...
Medtronic Biotech Presence: “Pawn Or Rook?” Is VP Oesterle’s Challenge
Biologics delivery to aid organ restoration is a frontier that will permit Medtronic to advance beyond its core strengths in electromechanical implants, according to Senior VP-Medicine & Technology Stephen Oesterle